- Home
- RNA vs GFF Comparison
RNA vs GFF Comparison
Compare RNA & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | GFF |
|---|---|---|
| Founded | 2012 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | GFF |
|---|---|---|
| Price | $71.58 | $74.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 4 |
| Target Price | $69.26 | ★ $95.75 |
| AVG Volume (30 Days) | ★ 3.7M | 360.9K |
| Earning Date | 11-10-2025 | 11-19-2025 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | $20,868,000.00 | ★ $2,519,926,000.00 |
| Revenue This Year | N/A | $1.87 |
| Revenue Next Year | $108.97 | $3.39 |
| P/E Ratio | ★ N/A | $68.01 |
| Revenue Growth | ★ 106.27 | N/A |
| 52 Week Low | $21.51 | $63.92 |
| 52 Week High | $71.78 | $84.42 |
Technical Indicators
Market Signals| Indicator | RNA | GFF |
|---|---|---|
| Relative Strength Index (RSI) | 77.70 | 54.46 |
| Support Level | $70.42 | $65.01 |
| Resistance Level | $71.78 | $76.07 |
| Average True Range (ATR) | 0.45 | 2.76 |
| MACD | -0.77 | 0.69 |
| Stochastic Oscillator | 85.66 | 83.91 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.